| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rural Population | 119 | 2024 | 624 | 12.380 |
Why?
|
| South Africa | 223 | 2024 | 7312 | 4.430 |
Why?
|
| Population Surveillance | 53 | 2021 | 325 | 4.180 |
Why?
|
| Cause of Death | 37 | 2022 | 206 | 4.130 |
Why?
|
| Humans | 261 | 2024 | 14077 | 3.980 |
Why?
|
| Hypertension | 30 | 2023 | 397 | 3.960 |
Why?
|
| Aged | 89 | 2024 | 1650 | 3.610 |
Why?
|
| Rural Health | 31 | 2019 | 118 | 3.480 |
Why?
|
| Female | 176 | 2024 | 8751 | 3.480 |
Why?
|
| Middle Aged | 111 | 2024 | 3425 | 3.440 |
Why?
|
| Male | 145 | 2024 | 6489 | 3.310 |
Why?
|
| Mortality | 18 | 2021 | 101 | 2.980 |
Why?
|
| HIV Infections | 66 | 2024 | 4946 | 2.890 |
Why?
|
| Cardiovascular Diseases | 17 | 2023 | 235 | 2.880 |
Why?
|
| Adult | 127 | 2024 | 5664 | 2.820 |
Why?
|
| Cognition | 14 | 2024 | 75 | 2.510 |
Why?
|
| Health Status | 15 | 2024 | 111 | 2.460 |
Why?
|
| Aging | 14 | 2024 | 109 | 2.400 |
Why?
|
| Socioeconomic Factors | 38 | 2019 | 405 | 2.350 |
Why?
|
| Adolescent | 83 | 2024 | 2858 | 2.280 |
Why?
|
| Risk Factors | 52 | 2023 | 1431 | 2.200 |
Why?
|
| Pensions | 4 | 2018 | 5 | 2.150 |
Why?
|
| Demography | 23 | 2021 | 105 | 1.840 |
Why?
|
| Primary Health Care | 22 | 2021 | 228 | 1.800 |
Why?
|
| Patient Acceptance of Health Care | 13 | 2023 | 235 | 1.780 |
Why?
|
| Longitudinal Studies | 38 | 2024 | 409 | 1.780 |
Why?
|
| Chronic Disease | 8 | 2023 | 100 | 1.610 |
Why?
|
| Autopsy | 24 | 2022 | 131 | 1.600 |
Why?
|
| Young Adult | 51 | 2024 | 2357 | 1.570 |
Why?
|
| Quality of Life | 6 | 2018 | 170 | 1.560 |
Why?
|
| Blood Pressure | 16 | 2023 | 312 | 1.560 |
Why?
|
| Cross-Sectional Studies | 45 | 2022 | 1377 | 1.500 |
Why?
|
| Child | 50 | 2023 | 2180 | 1.490 |
Why?
|
| Stroke | 7 | 2016 | 59 | 1.470 |
Why?
|
| Developing Countries | 18 | 2021 | 385 | 1.380 |
Why?
|
| Diabetes Mellitus | 10 | 2023 | 137 | 1.370 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 449 | 1.360 |
Why?
|
| Rural Health Services | 9 | 2018 | 48 | 1.290 |
Why?
|
| Prevalence | 35 | 2023 | 1149 | 1.270 |
Why?
|
| Tuberculosis, Pulmonary | 8 | 2014 | 320 | 1.260 |
Why?
|
| Health Services Accessibility | 15 | 2021 | 265 | 1.200 |
Why?
|
| Age Factors | 20 | 2019 | 364 | 1.150 |
Why?
|
| Genome-Wide Association Study | 8 | 2023 | 100 | 1.110 |
Why?
|
| Transients and Migrants | 8 | 2024 | 39 | 1.100 |
Why?
|
| Health Services Research | 10 | 2021 | 57 | 1.090 |
Why?
|
| Public Health | 6 | 2024 | 122 | 1.090 |
Why?
|
| Disabled Persons | 3 | 2020 | 23 | 1.080 |
Why?
|
| Sexual Behavior | 9 | 2021 | 313 | 1.070 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2022 | 23 | 1.070 |
Why?
|
| Child Mortality | 7 | 2019 | 93 | 1.060 |
Why?
|
| Interviews as Topic | 15 | 2019 | 190 | 1.060 |
Why?
|
| Child, Preschool | 32 | 2022 | 1675 | 1.050 |
Why?
|
| Infant Mortality | 7 | 2019 | 92 | 1.030 |
Why?
|
| Overweight | 9 | 2020 | 84 | 1.020 |
Why?
|
| Surveys and Questionnaires | 25 | 2023 | 532 | 1.010 |
Why?
|
| Obesity | 13 | 2024 | 356 | 1.000 |
Why?
|
| Metabolic Diseases | 4 | 2019 | 30 | 1.000 |
Why?
|
| Body Mass Index | 15 | 2021 | 312 | 0.980 |
Why?
|
| Infant | 32 | 2020 | 2145 | 0.970 |
Why?
|
| Activities of Daily Living | 5 | 2021 | 39 | 0.970 |
Why?
|
| Community Health Services | 10 | 2018 | 58 | 0.960 |
Why?
|
| Self Report | 10 | 2020 | 111 | 0.950 |
Why?
|
| Delivery of Health Care, Integrated | 4 | 2018 | 33 | 0.950 |
Why?
|
| Social Conditions | 2 | 2014 | 10 | 0.930 |
Why?
|
| Infant, Newborn | 23 | 2021 | 1410 | 0.930 |
Why?
|
| Data Collection | 8 | 2021 | 86 | 0.920 |
Why?
|
| Sex Distribution | 14 | 2018 | 89 | 0.910 |
Why?
|
| Global Health | 7 | 2018 | 183 | 0.910 |
Why?
|
| Maternal Mortality | 7 | 2015 | 54 | 0.890 |
Why?
|
| Poverty | 11 | 2021 | 149 | 0.860 |
Why?
|
| Sex Factors | 12 | 2019 | 224 | 0.840 |
Why?
|
| Communicable Diseases | 3 | 2017 | 61 | 0.790 |
Why?
|
| Delivery of Health Care | 10 | 2024 | 230 | 0.790 |
Why?
|
| Health Policy | 8 | 2019 | 132 | 0.780 |
Why?
|
| Incidence | 16 | 2022 | 655 | 0.780 |
Why?
|
| Death Certificates | 4 | 2016 | 10 | 0.770 |
Why?
|
| Pregnancy | 14 | 2023 | 1815 | 0.750 |
Why?
|
| Data Accuracy | 1 | 2021 | 9 | 0.740 |
Why?
|
| Health Transition | 5 | 2016 | 11 | 0.730 |
Why?
|
| Registries | 4 | 2016 | 89 | 0.720 |
Why?
|
| Vaccines | 1 | 2022 | 84 | 0.720 |
Why?
|
| Atherosclerosis | 5 | 2022 | 97 | 0.720 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 112 | 0.700 |
Why?
|
| Epilepsy | 5 | 2020 | 17 | 0.700 |
Why?
|
| Health Status Disparities | 4 | 2017 | 34 | 0.690 |
Why?
|
| Cost of Illness | 8 | 2015 | 155 | 0.680 |
Why?
|
| Health Priorities | 5 | 2017 | 62 | 0.670 |
Why?
|
| Social Class | 5 | 2018 | 72 | 0.660 |
Why?
|
| Exercise | 6 | 2021 | 203 | 0.660 |
Why?
|
| Research | 7 | 2017 | 65 | 0.630 |
Why?
|
| Cohort Studies | 15 | 2024 | 939 | 0.600 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2018 | 4 | 0.600 |
Why?
|
| Executive Function | 4 | 2023 | 23 | 0.590 |
Why?
|
| Physician's Role | 3 | 2014 | 8 | 0.590 |
Why?
|
| Community-Based Participatory Research | 4 | 2019 | 24 | 0.590 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2007 | 194 | 0.560 |
Why?
|
| Emigration and Immigration | 3 | 2014 | 13 | 0.550 |
Why?
|
| Multimorbidity | 3 | 2023 | 42 | 0.550 |
Why?
|
| Birth Certificates | 1 | 2016 | 4 | 0.550 |
Why?
|
| Value of Life | 1 | 2016 | 2 | 0.540 |
Why?
|
| Verbal Behavior | 5 | 2019 | 11 | 0.540 |
Why?
|
| Qualitative Research | 7 | 2023 | 294 | 0.540 |
Why?
|
| Life Style | 5 | 2020 | 80 | 0.530 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2016 | 186 | 0.530 |
Why?
|
| Life Expectancy | 3 | 2017 | 31 | 0.520 |
Why?
|
| Eligibility Determination | 1 | 2015 | 16 | 0.520 |
Why?
|
| Genomics | 6 | 2023 | 106 | 0.510 |
Why?
|
| Neonatology | 1 | 2015 | 1 | 0.500 |
Why?
|
| Pregnancy in Adolescence | 2 | 2015 | 14 | 0.500 |
Why?
|
| Pediatrics | 1 | 2015 | 16 | 0.500 |
Why?
|
| Depression | 3 | 2022 | 117 | 0.500 |
Why?
|
| Student Dropouts | 1 | 2015 | 8 | 0.490 |
Why?
|
| Mental Disorders | 5 | 2023 | 40 | 0.490 |
Why?
|
| Public Policy | 5 | 2021 | 24 | 0.480 |
Why?
|
| Carotid Intima-Media Thickness | 5 | 2022 | 104 | 0.480 |
Why?
|
| Medicine, African Traditional | 1 | 2014 | 24 | 0.480 |
Why?
|
| Disease Management | 4 | 2020 | 73 | 0.470 |
Why?
|
| Educational Status | 6 | 2019 | 68 | 0.470 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2021 | 247 | 0.470 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 63 | 0.460 |
Why?
|
| Spatial Analysis | 2 | 2013 | 9 | 0.460 |
Why?
|
| Students | 4 | 2020 | 48 | 0.460 |
Why?
|
| Africa | 13 | 2021 | 360 | 0.450 |
Why?
|
| Income | 6 | 2021 | 83 | 0.450 |
Why?
|
| HIV Seropositivity | 2 | 2020 | 263 | 0.450 |
Why?
|
| Anti-Retroviral Agents | 6 | 2020 | 542 | 0.440 |
Why?
|
| Age Distribution | 9 | 2016 | 106 | 0.440 |
Why?
|
| Adiposity | 3 | 2021 | 95 | 0.440 |
Why?
|
| Pilot Projects | 8 | 2022 | 168 | 0.440 |
Why?
|
| Food Industry | 1 | 2013 | 11 | 0.440 |
Why?
|
| Antihypertensive Agents | 7 | 2023 | 61 | 0.430 |
Why?
|
| Risk Assessment | 3 | 2023 | 217 | 0.430 |
Why?
|
| Caregivers | 2 | 2016 | 66 | 0.420 |
Why?
|
| Documentation | 1 | 2012 | 3 | 0.410 |
Why?
|
| Health Promotion | 5 | 2018 | 108 | 0.410 |
Why?
|
| Population Dynamics | 5 | 2017 | 27 | 0.400 |
Why?
|
| Literacy | 4 | 2020 | 9 | 0.400 |
Why?
|
| Quality-Adjusted Life Years | 6 | 2020 | 26 | 0.400 |
Why?
|
| Disease Outbreaks | 8 | 2007 | 111 | 0.390 |
Why?
|
| Urinalysis | 2 | 2022 | 15 | 0.390 |
Why?
|
| Epidemics | 2 | 2024 | 64 | 0.390 |
Why?
|
| Models, Statistical | 5 | 2017 | 53 | 0.390 |
Why?
|
| Prospective Studies | 13 | 2024 | 1131 | 0.380 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 16 | 0.380 |
Why?
|
| History, 20th Century | 6 | 2015 | 22 | 0.380 |
Why?
|
| Health Plan Implementation | 2 | 2019 | 16 | 0.370 |
Why?
|
| Urban Population | 6 | 2018 | 246 | 0.370 |
Why?
|
| Patient Compliance | 4 | 2020 | 120 | 0.370 |
Why?
|
| Microbiota | 2 | 2022 | 30 | 0.370 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 68 | 0.360 |
Why?
|
| Sexual Partners | 7 | 2021 | 211 | 0.360 |
Why?
|
| Herpes Genitalis | 4 | 2019 | 42 | 0.350 |
Why?
|
| Health Care Reform | 3 | 2013 | 20 | 0.350 |
Why?
|
| Community Health Workers | 4 | 2022 | 62 | 0.350 |
Why?
|
| Motivation | 4 | 2020 | 56 | 0.350 |
Why?
|
| Blood Glucose | 4 | 2021 | 106 | 0.340 |
Why?
|
| Frailty | 2 | 2021 | 15 | 0.340 |
Why?
|
| Ghana | 8 | 2022 | 62 | 0.340 |
Why?
|
| Bayes Theorem | 4 | 2015 | 77 | 0.330 |
Why?
|
| Logistic Models | 6 | 2015 | 252 | 0.330 |
Why?
|
| Alcohol Drinking | 3 | 2021 | 53 | 0.320 |
Why?
|
| Herpesvirus 2, Human | 3 | 2019 | 42 | 0.320 |
Why?
|
| Measles | 2 | 2023 | 36 | 0.320 |
Why?
|
| Research Design | 3 | 2014 | 123 | 0.320 |
Why?
|
| Time Factors | 5 | 2018 | 503 | 0.320 |
Why?
|
| HIV | 4 | 2021 | 380 | 0.320 |
Why?
|
| Sodium, Dietary | 2 | 2022 | 10 | 0.310 |
Why?
|
| Refugees | 3 | 2018 | 10 | 0.300 |
Why?
|
| Medication Adherence | 3 | 2020 | 137 | 0.300 |
Why?
|
| Dyslipidemias | 2 | 2019 | 47 | 0.300 |
Why?
|
| Community Health Centers | 4 | 2004 | 9 | 0.300 |
Why?
|
| Public Health Surveillance | 4 | 2018 | 52 | 0.290 |
Why?
|
| Proportional Hazards Models | 4 | 2015 | 163 | 0.290 |
Why?
|
| Awareness | 2 | 2017 | 18 | 0.290 |
Why?
|
| Mental Health | 3 | 2023 | 86 | 0.280 |
Why?
|
| Creatinine | 3 | 2022 | 51 | 0.280 |
Why?
|
| Capacity Building | 2 | 2017 | 32 | 0.280 |
Why?
|
| Eating | 2 | 2017 | 16 | 0.280 |
Why?
|
| Social Stigma | 4 | 2020 | 76 | 0.280 |
Why?
|
| Ankle | 1 | 2006 | 3 | 0.280 |
Why?
|
| Body Image | 2 | 2017 | 17 | 0.280 |
Why?
|
| Brachial Artery | 1 | 2006 | 29 | 0.270 |
Why?
|
| Health Services Needs and Demand | 5 | 2019 | 57 | 0.270 |
Why?
|
| Ambulatory Care | 2 | 2017 | 54 | 0.270 |
Why?
|
| Epilepsy, Generalized | 2 | 2016 | 3 | 0.270 |
Why?
|
| Drama | 1 | 2006 | 2 | 0.260 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 10 | 0.260 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 48 | 0.260 |
Why?
|
| Dementia | 2 | 2024 | 16 | 0.260 |
Why?
|
| Comorbidity | 5 | 2019 | 184 | 0.260 |
Why?
|
| Parents | 2 | 2023 | 29 | 0.250 |
Why?
|
| Diet | 3 | 2020 | 108 | 0.250 |
Why?
|
| Health Surveys | 3 | 2019 | 59 | 0.250 |
Why?
|
| Asia | 8 | 2021 | 70 | 0.250 |
Why?
|
| Waist-Hip Ratio | 2 | 2017 | 22 | 0.250 |
Why?
|
| Frail Elderly | 3 | 2021 | 15 | 0.240 |
Why?
|
| Social Medicine | 2 | 2002 | 3 | 0.240 |
Why?
|
| Program Evaluation | 4 | 2017 | 89 | 0.240 |
Why?
|
| Albuminuria | 2 | 2022 | 20 | 0.240 |
Why?
|
| Maternal Health Services | 2 | 2023 | 51 | 0.240 |
Why?
|
| Pregnancy Rate | 2 | 2015 | 8 | 0.230 |
Why?
|
| Marital Status | 2 | 2014 | 11 | 0.230 |
Why?
|
| Geography | 3 | 2021 | 60 | 0.230 |
Why?
|
| Immunization Programs | 3 | 2013 | 78 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2019 | 767 | 0.230 |
Why?
|
| Anthropometry | 4 | 2018 | 101 | 0.230 |
Why?
|
| Decision Making | 1 | 2024 | 52 | 0.230 |
Why?
|
| Fertility | 5 | 2013 | 22 | 0.220 |
Why?
|
| Pandemics | 2 | 2023 | 280 | 0.220 |
Why?
|
| Cost-Benefit Analysis | 5 | 2020 | 235 | 0.220 |
Why?
|
| Smoking | 3 | 2021 | 99 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 30 | 0.220 |
Why?
|
| Residence Characteristics | 6 | 2021 | 56 | 0.220 |
Why?
|
| Memory, Episodic | 1 | 2023 | 3 | 0.210 |
Why?
|
| Travel | 2 | 2020 | 21 | 0.210 |
Why?
|
| Body Height | 3 | 2018 | 51 | 0.210 |
Why?
|
| Child Health Services | 2 | 2013 | 33 | 0.210 |
Why?
|
| Behavior Therapy | 1 | 2022 | 11 | 0.210 |
Why?
|
| Maternal Age | 4 | 2015 | 22 | 0.210 |
Why?
|
| Anticonvulsants | 2 | 2020 | 13 | 0.210 |
Why?
|
| Community Health Planning | 1 | 2002 | 3 | 0.210 |
Why?
|
| Public Health Practice | 1 | 2002 | 7 | 0.210 |
Why?
|
| Family Characteristics | 3 | 2013 | 133 | 0.210 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 17 | 0.210 |
Why?
|
| Health Planning | 3 | 2000 | 13 | 0.210 |
Why?
|
| Education | 3 | 2018 | 22 | 0.200 |
Why?
|
| Tuberculosis | 7 | 2017 | 530 | 0.200 |
Why?
|
| Databases, Factual | 7 | 2014 | 64 | 0.200 |
Why?
|
| Kidney | 1 | 2022 | 46 | 0.200 |
Why?
|
| Helsinki Declaration | 1 | 2001 | 1 | 0.200 |
Why?
|
| Human Experimentation | 1 | 2001 | 2 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2023 | 95 | 0.200 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 32 | 0.200 |
Why?
|
| Emigrants and Immigrants | 2 | 2018 | 11 | 0.200 |
Why?
|
| Internationality | 1 | 2001 | 34 | 0.190 |
Why?
|
| Linear Models | 6 | 2019 | 82 | 0.190 |
Why?
|
| Mass Screening | 3 | 2020 | 242 | 0.190 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 171 | 0.190 |
Why?
|
| Interdisciplinary Placement | 1 | 2021 | 4 | 0.190 |
Why?
|
| Drug Misuse | 1 | 2021 | 1 | 0.190 |
Why?
|
| Gene Flow | 1 | 2021 | 9 | 0.190 |
Why?
|
| Language | 1 | 2021 | 13 | 0.190 |
Why?
|
| Glycated Hemoglobin A | 2 | 2021 | 24 | 0.190 |
Why?
|
| Schools | 2 | 2019 | 67 | 0.180 |
Why?
|
| Wounds and Injuries | 2 | 2019 | 26 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 55 | 0.180 |
Why?
|
| Africa South of the Sahara | 6 | 2022 | 328 | 0.180 |
Why?
|
| Waist Circumference | 3 | 2018 | 53 | 0.180 |
Why?
|
| Health Resources | 3 | 2021 | 65 | 0.180 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2020 | 2 | 0.180 |
Why?
|
| Point-of-Care Systems | 2 | 2021 | 88 | 0.180 |
Why?
|
| Health Behavior | 1 | 2021 | 78 | 0.180 |
Why?
|
| World Health Organization | 3 | 2019 | 134 | 0.180 |
Why?
|
| Point-of-Care Testing | 1 | 2021 | 68 | 0.180 |
Why?
|
| Developed Countries | 2 | 2018 | 23 | 0.170 |
Why?
|
| Adolescent Behavior | 2 | 2018 | 58 | 0.170 |
Why?
|
| Blood Pressure Determination | 3 | 2017 | 27 | 0.170 |
Why?
|
| Odds Ratio | 3 | 2015 | 132 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2017 | 78 | 0.170 |
Why?
|
| Health Services | 3 | 2022 | 44 | 0.170 |
Why?
|
| Social Support | 1 | 2020 | 76 | 0.170 |
Why?
|
| Probability | 3 | 2020 | 27 | 0.170 |
Why?
|
| Witchcraft | 2 | 2011 | 3 | 0.170 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 41 | 0.170 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 137 | 0.170 |
Why?
|
| Case Management | 1 | 2019 | 5 | 0.170 |
Why?
|
| Social Mobility | 1 | 2019 | 1 | 0.170 |
Why?
|
| Systems Integration | 1 | 2019 | 3 | 0.170 |
Why?
|
| Psychometrics | 2 | 2016 | 20 | 0.160 |
Why?
|
| Health Education | 1 | 2019 | 35 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2019 | 53 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 132 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 10 | 0.160 |
Why?
|
| Social Justice | 1 | 1998 | 6 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 12 | 0.160 |
Why?
|
| Urbanization | 2 | 2019 | 11 | 0.160 |
Why?
|
| Nurses | 2 | 2020 | 32 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 274 | 0.160 |
Why?
|
| Health Care Rationing | 1 | 1998 | 16 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 176 | 0.160 |
Why?
|
| Measles Vaccine | 4 | 2013 | 34 | 0.160 |
Why?
|
| Health Equity | 1 | 2018 | 10 | 0.160 |
Why?
|
| Violence | 3 | 2016 | 68 | 0.160 |
Why?
|
| Mozambique | 4 | 2021 | 52 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 33 | 0.150 |
Why?
|
| Kenya | 4 | 2021 | 173 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2018 | 35 | 0.150 |
Why?
|
| Physical Fitness | 1 | 2018 | 10 | 0.150 |
Why?
|
| Genetic Variation | 2 | 2021 | 169 | 0.150 |
Why?
|
| Menarche | 1 | 2018 | 13 | 0.150 |
Why?
|
| Datasets as Topic | 2 | 2019 | 15 | 0.150 |
Why?
|
| Leg | 1 | 2018 | 21 | 0.150 |
Why?
|
| Genetics, Medical | 2 | 2014 | 21 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 11 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2018 | 40 | 0.150 |
Why?
|
| Patient Participation | 1 | 2018 | 13 | 0.150 |
Why?
|
| Maternal Death | 2 | 2015 | 25 | 0.150 |
Why?
|
| Patient Selection | 1 | 2018 | 40 | 0.150 |
Why?
|
| Survival Rate | 3 | 2019 | 96 | 0.150 |
Why?
|
| Psychosocial Deprivation | 1 | 2017 | 2 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2018 | 867 | 0.150 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Body Composition | 1 | 2018 | 150 | 0.140 |
Why?
|
| Pediatric Obesity | 2 | 2015 | 40 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2021 | 360 | 0.140 |
Why?
|
| Nutritional Status | 3 | 2013 | 75 | 0.140 |
Why?
|
| Self-Help Groups | 1 | 1997 | 3 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 210 | 0.140 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 17 | 0.140 |
Why?
|
| Vulnerable Populations | 2 | 2010 | 30 | 0.140 |
Why?
|
| Remuneration | 1 | 2016 | 2 | 0.140 |
Why?
|
| Markov Chains | 2 | 2020 | 20 | 0.140 |
Why?
|
| Lipids | 1 | 2017 | 81 | 0.140 |
Why?
|
| Urban Health | 1 | 2017 | 78 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 468 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 96 | 0.140 |
Why?
|
| Burkina Faso | 3 | 2021 | 29 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 16 | 0.130 |
Why?
|
| Attitude | 1 | 2016 | 12 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 2 | 2015 | 125 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 13 | 0.130 |
Why?
|
| Uganda | 3 | 2023 | 194 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2016 | 34 | 0.130 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 5 | 0.120 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2015 | 19 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 392 | 0.120 |
Why?
|
| Neoplasms | 3 | 2013 | 141 | 0.120 |
Why?
|
| Viral Load | 4 | 2019 | 808 | 0.120 |
Why?
|
| Accidents | 2 | 2013 | 5 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2015 | 59 | 0.120 |
Why?
|
| Health Personnel | 3 | 2022 | 229 | 0.120 |
Why?
|
| Condoms | 1 | 2015 | 86 | 0.120 |
Why?
|
| Genome, Human | 1 | 2014 | 24 | 0.120 |
Why?
|
| Disease | 1 | 2014 | 12 | 0.120 |
Why?
|
| Dermatoglyphics | 1 | 2014 | 2 | 0.120 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 6 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2014 | 37 | 0.120 |
Why?
|
| Adolescent Health Services | 1 | 2014 | 16 | 0.120 |
Why?
|
| Mental Health Services | 1 | 2014 | 9 | 0.120 |
Why?
|
| House Calls | 1 | 2014 | 8 | 0.110 |
Why?
|
| Models, Biological | 1 | 2014 | 77 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2013 | 9 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 1994 | 110 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 10 | 0.110 |
Why?
|
| Curriculum | 2 | 1994 | 27 | 0.110 |
Why?
|
| Body Weight | 2 | 2011 | 110 | 0.110 |
Why?
|
| Birth Intervals | 1 | 2013 | 3 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 102 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 2013 | 2 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2013 | 7 | 0.110 |
Why?
|
| Psychology, Child | 1 | 2013 | 3 | 0.110 |
Why?
|
| Mass Vaccination | 1 | 2013 | 11 | 0.110 |
Why?
|
| Information Services | 1 | 2013 | 4 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 2013 | 9 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2014 | 107 | 0.110 |
Why?
|
| Cell Phone | 1 | 2013 | 34 | 0.110 |
Why?
|
| Taxes | 1 | 2013 | 73 | 0.110 |
Why?
|
| Schools, Public Health | 1 | 1992 | 7 | 0.100 |
Why?
|
| United States | 5 | 2014 | 129 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Prenatal Care | 2 | 2023 | 141 | 0.100 |
Why?
|
| Education, Graduate | 1 | 1992 | 10 | 0.100 |
Why?
|
| Reference Standards | 1 | 2012 | 29 | 0.100 |
Why?
|
| Food | 1 | 2012 | 11 | 0.100 |
Why?
|
| Emotions | 2 | 2023 | 18 | 0.100 |
Why?
|
| Focus Groups | 3 | 2020 | 180 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2004 | 22 | 0.100 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 41 | 0.100 |
Why?
|
| Speech | 1 | 2011 | 4 | 0.100 |
Why?
|
| Employment | 2 | 2024 | 27 | 0.100 |
Why?
|
| Anti-HIV Agents | 2 | 2017 | 1275 | 0.100 |
Why?
|
| Phenotype | 2 | 2023 | 144 | 0.100 |
Why?
|
| Immunization | 1 | 2012 | 63 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 61 | 0.100 |
Why?
|
| Seroepidemiologic Studies | 2 | 2022 | 104 | 0.100 |
Why?
|
| Space-Time Clustering | 1 | 2011 | 6 | 0.090 |
Why?
|
| Geographic Information Systems | 1 | 2011 | 5 | 0.090 |
Why?
|
| Risk | 3 | 2016 | 87 | 0.090 |
Why?
|
| Mothers | 1 | 2013 | 190 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 19 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 11 | 0.090 |
Why?
|
| Malaria | 1 | 2013 | 207 | 0.090 |
Why?
|
| Malnutrition | 1 | 2011 | 53 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2010 | 31 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2021 | 119 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 1990 | 4 | 0.090 |
Why?
|
| Forecasting | 3 | 2009 | 20 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2010 | 56 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 137 | 0.080 |
Why?
|
| Vietnam | 2 | 2021 | 11 | 0.080 |
Why?
|
| Bangladesh | 2 | 2021 | 14 | 0.080 |
Why?
|
| Unsafe Sex | 2 | 2020 | 45 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 367 | 0.080 |
Why?
|
| Long-Term Care | 2 | 2020 | 13 | 0.080 |
Why?
|
| National Health Programs | 1 | 2009 | 78 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2018 | 131 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 380 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 237 | 0.080 |
Why?
|
| Communicable Disease Control | 2 | 2022 | 101 | 0.080 |
Why?
|
| School Health Services | 1 | 2008 | 19 | 0.070 |
Why?
|
| Culture | 1 | 2007 | 21 | 0.070 |
Why?
|
| Medicine, Traditional | 1 | 2007 | 7 | 0.070 |
Why?
|
| Community Networks | 1 | 2007 | 13 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 26 | 0.070 |
Why?
|
| Schools, Medical | 2 | 1999 | 8 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2007 | 56 | 0.070 |
Why?
|
| Software | 2 | 2019 | 36 | 0.070 |
Why?
|
| Multilevel Analysis | 2 | 2019 | 8 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 6 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2020 | 464 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 45 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2020 | 654 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2017 | 58 | 0.070 |
Why?
|
| Child Development | 1 | 2008 | 89 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2021 | 25 | 0.070 |
Why?
|
| Politics | 3 | 2009 | 23 | 0.070 |
Why?
|
| Medical Audit | 1 | 2006 | 26 | 0.070 |
Why?
|
| Risk Reduction Behavior | 2 | 2016 | 39 | 0.060 |
Why?
|
| Confidentiality | 2 | 2016 | 13 | 0.060 |
Why?
|
| Diarrhea | 3 | 2000 | 76 | 0.060 |
Why?
|
| Contraception Behavior | 2 | 2007 | 54 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 103 | 0.060 |
Why?
|
| Survivors | 1 | 2004 | 5 | 0.060 |
Why?
|
| Motor Activity | 2 | 2015 | 46 | 0.060 |
Why?
|
| Preventive Health Services | 1 | 2004 | 17 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 2 | 0.060 |
Why?
|
| Program Development | 2 | 2014 | 32 | 0.050 |
Why?
|
| Public Sector | 1 | 2024 | 82 | 0.050 |
Why?
|
| Vitamin A | 2 | 2013 | 10 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 13 | 0.050 |
Why?
|
| Poliovirus Vaccines | 2 | 2013 | 11 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 76 | 0.050 |
Why?
|
| Vitamins | 2 | 2013 | 23 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2022 | 17 | 0.050 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 6 | 0.050 |
Why?
|
| Anxiety | 1 | 2023 | 39 | 0.050 |
Why?
|
| Social Change | 1 | 2002 | 14 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 25 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 26 | 0.050 |
Why?
|
| Fear | 1 | 2022 | 11 | 0.050 |
Why?
|
| Cystatin C | 1 | 2022 | 9 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 190 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 56 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Malawi | 1 | 2022 | 86 | 0.050 |
Why?
|
| Metagenomics | 1 | 2022 | 8 | 0.050 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2001 | 1 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2001 | 3 | 0.050 |
Why?
|
| Drug Industry | 1 | 2001 | 4 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 46 | 0.050 |
Why?
|
| Placebos | 1 | 2001 | 44 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2021 | 35 | 0.050 |
Why?
|
| Fasting | 1 | 2021 | 14 | 0.050 |
Why?
|
| Echocardiography | 1 | 2021 | 99 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 7 | 0.050 |
Why?
|
| Linguistics | 1 | 2021 | 5 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2021 | 9 | 0.050 |
Why?
|
| Iohexol | 1 | 2021 | 7 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2021 | 14 | 0.050 |
Why?
|
| Thailand | 1 | 2021 | 24 | 0.050 |
Why?
|
| African Americans | 1 | 2021 | 47 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2021 | 65 | 0.050 |
Why?
|
| Recurrence | 1 | 2020 | 27 | 0.050 |
Why?
|
| Medical Records | 1 | 2000 | 22 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 18 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2021 | 117 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2021 | 50 | 0.050 |
Why?
|
| Feces | 1 | 2020 | 30 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2021 | 77 | 0.050 |
Why?
|
| HIV Seronegativity | 1 | 2020 | 52 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 119 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 46 | 0.040 |
Why?
|
| Seizures | 1 | 2020 | 20 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 231 | 0.040 |
Why?
|
| Contraception | 1 | 2020 | 90 | 0.040 |
Why?
|
| Population Density | 1 | 1999 | 13 | 0.040 |
Why?
|
| Censuses | 1 | 1999 | 2 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 32 | 0.040 |
Why?
|
| Afghanistan | 1 | 2019 | 3 | 0.040 |
Why?
|
| Uncertainty | 1 | 2019 | 7 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 14 | 0.040 |
Why?
|
| Population Health | 1 | 2019 | 10 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 322 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 14 | 0.040 |
Why?
|
| Emtricitabine | 1 | 2019 | 74 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2019 | 6 | 0.040 |
Why?
|
| Lamivudine | 1 | 2019 | 86 | 0.040 |
Why?
|
| Blood | 1 | 2019 | 51 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 1998 | 5 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2018 | 14 | 0.040 |
Why?
|
| Human Rights | 1 | 2018 | 12 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 59 | 0.040 |
Why?
|
| Primary Prevention | 2 | 2009 | 27 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 78 | 0.040 |
Why?
|
| Gender Identity | 1 | 2018 | 23 | 0.040 |
Why?
|
| Extramarital Relations | 1 | 2018 | 2 | 0.040 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2018 | 2 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 9 | 0.040 |
Why?
|
| Bias | 1 | 2018 | 12 | 0.040 |
Why?
|
| Intimate Partner Violence | 1 | 2018 | 52 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 37 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 9 | 0.040 |
Why?
|
| Disclosure | 1 | 2017 | 25 | 0.040 |
Why?
|
| Health | 2 | 2014 | 11 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2017 | 20 | 0.040 |
Why?
|
| Mice | 1 | 2017 | 134 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2017 | 5 | 0.040 |
Why?
|
| HIV Antibodies | 1 | 2019 | 243 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2017 | 64 | 0.030 |
Why?
|
| Cognitive Reserve | 1 | 2016 | 2 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 43 | 0.030 |
Why?
|
| Fees and Charges | 1 | 2016 | 6 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 80 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2016 | 12 | 0.030 |
Why?
|
| Outpatients | 1 | 2016 | 36 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2016 | 6 | 0.030 |
Why?
|
| Puberty | 1 | 2016 | 22 | 0.030 |
Why?
|
| Social Welfare | 1 | 2015 | 3 | 0.030 |
Why?
|
| India | 1 | 2015 | 60 | 0.030 |
Why?
|
| Public Assistance | 1 | 2015 | 5 | 0.030 |
Why?
|
| Physicians | 1 | 2015 | 30 | 0.030 |
Why?
|
| Counseling | 1 | 2016 | 136 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 20 | 0.030 |
Why?
|
| Child Behavior | 1 | 2015 | 11 | 0.030 |
Why?
|
| Child, Orphaned | 1 | 2015 | 16 | 0.030 |
Why?
|
| Commerce | 1 | 2015 | 20 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2014 | 11 | 0.030 |
Why?
|
| Europe | 1 | 2014 | 53 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 31 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2014 | 24 | 0.030 |
Why?
|
| Vital Statistics | 1 | 2014 | 10 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 11 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 1063 | 0.030 |
Why?
|
| England | 1 | 2014 | 15 | 0.030 |
Why?
|
| Patient Identification Systems | 1 | 2014 | 4 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2014 | 149 | 0.030 |
Why?
|
| Education, Medical | 1 | 1994 | 7 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2013 | 9 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 16 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 32 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2013 | 30 | 0.030 |
Why?
|
| Oceania | 1 | 2013 | 2 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2013 | 6 | 0.030 |
Why?
|
| Tanzania | 1 | 2013 | 84 | 0.030 |
Why?
|
| Brain | 1 | 2013 | 53 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 64 | 0.030 |
Why?
|
| Helminthiasis | 1 | 2013 | 7 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2013 | 9 | 0.030 |
Why?
|
| Unemployment | 1 | 2013 | 10 | 0.030 |
Why?
|
| Planning Techniques | 1 | 1992 | 1 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1992 | 2 | 0.030 |
Why?
|
| Boston | 1 | 1992 | 2 | 0.030 |
Why?
|
| Role | 1 | 1992 | 4 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 1992 | 6 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 1992 | 8 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 1993 | 14 | 0.030 |
Why?
|
| Clinical Competence | 1 | 1992 | 13 | 0.030 |
Why?
|
| Community Participation | 1 | 1993 | 42 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 1992 | 6 | 0.020 |
Why?
|
| Sweden | 1 | 2011 | 5 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2011 | 2 | 0.020 |
Why?
|
| Complementary Therapies | 1 | 2011 | 3 | 0.020 |
Why?
|
| Israel | 1 | 1991 | 2 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 105 | 0.020 |
Why?
|
| Terminal Care | 1 | 2011 | 34 | 0.020 |
Why?
|
| HIV-1 | 1 | 2019 | 1239 | 0.020 |
Why?
|
| Vaccination | 1 | 1992 | 347 | 0.020 |
Why?
|
| Indonesia | 1 | 1990 | 7 | 0.020 |
Why?
|
| South America | 1 | 1990 | 26 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 17 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 21 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2009 | 20 | 0.020 |
Why?
|
| Leadership | 1 | 2009 | 20 | 0.020 |
Why?
|
| Internship and Residency | 1 | 1988 | 6 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 507 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 38 | 0.020 |
Why?
|
| Family Planning Services | 1 | 2007 | 46 | 0.020 |
Why?
|
| Sphygmomanometers | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 4 | 0.020 |
Why?
|
| Aspirin | 1 | 2006 | 15 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 18 | 0.020 |
Why?
|
| Consumer Behavior | 1 | 2006 | 20 | 0.020 |
Why?
|
| Primary Nursing | 1 | 2004 | 1 | 0.010 |
Why?
|
| Cough | 1 | 2004 | 13 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2000 | 13 | 0.010 |
Why?
|
| Africa, Western | 1 | 2000 | 6 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2001 | 103 | 0.010 |
Why?
|
| Sputum | 1 | 2001 | 135 | 0.010 |
Why?
|
| Birth Rate | 1 | 2000 | 5 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 183 | 0.010 |
Why?
|
| Kwashiorkor | 1 | 1999 | 4 | 0.010 |
Why?
|
| Sepsis | 1 | 2000 | 101 | 0.010 |
Why?
|
| Organization and Administration | 1 | 1993 | 2 | 0.010 |
Why?
|
| Behavior | 1 | 1993 | 5 | 0.010 |
Why?
|
| Health Systems Plans | 1 | 1992 | 1 | 0.010 |
Why?
|
| Systems Analysis | 1 | 1992 | 3 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1992 | 20 | 0.010 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1992 | 17 | 0.010 |
Why?
|
| Africa, Southern | 1 | 1993 | 89 | 0.010 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1992 | 28 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1993 | 43 | 0.010 |
Why?
|
| Work Schedule Tolerance | 1 | 1988 | 2 | 0.000 |
Why?
|
| Work | 1 | 1988 | 9 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1988 | 21 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 1988 | 25 | 0.000 |
Why?
|
| Sleep | 1 | 1988 | 35 | 0.000 |
Why?
|